G
Genpact LTD
Next earnings Aug 5, 2026 (after close) · consensus $0.98 EPS, $1.36B rev
Last earnings +2.0% on 2026-05-07
$29.10
▲ +4.49%$29.10▼ -31.93%
over 1Y
L $27.67H $47.98
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.5%
1W+5.2%
1M-11.4%
3M-22.4%
YTD-35.9%
1Y-31.9%
Buy
Conviction
Horizon
Medium (3–12mo)
Street · 20 analysts
Buy
Steady digital-operations compounder — revenue +6.6%, 21.7% ROE, strong cash flow — at a cheap 9x earnings, with AI as the swing factor.
Revenue $5.08B · FY2025
The read
Quality fundamentals and an attractive price line up (~126% below fair value) — the rarer case where both the business and the entry look good.
Genpact is a digital-operations and consulting firm that has delivered consistent, profitable growth. FY2025 revenue rose 6.6% to $5.08B, net income grew 7.6% to $552M (EPS $3.13, +9.8%), and the business sustained a 36.0% gross margin, 14.8% operating margin and a strong 21.7% return on equity. Cash generation is excellent — operating cash flow jumped 32.1% to $813M on light capex ($78M) — funding both buybacks (shares down 3.3%) and a growing dividend ($118M, +8.6%). The balance sheet is sound at 1.29x liabilities/equity with $854M cash, though the spike in current debt ($376M) bears watching as a near-term maturity.
At 9.0x earnings and 0.9x sales, the valuation is strikingly cheap for a company compounding earnings at a 20%+ ROE. The discount reflects the central debate around the stock: generative AI is both an opportunity and a threat to a business historically built on process and labor arbitrage. The market appears to be pricing in AI-disruption risk to the legacy BPO model.
Is G a buy? The one-page verdict, explained →
The options angle
model · matches our verdictBull call spread~60d expiry
- Long call 29 @ ~2.31 est
- Short call 32 @ ~1.17 est
debit $114max +$186max −$114BE 30.14
BUY verdict with defined risk: the short call finances part of the long one; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $4.02B | $4.37B | $4.48B | $4.77B | $5.08B |
| Gross profit | $1.43B | $1.54B | $1.57B | $1.69B | $1.83B |
| Operating income | $509M | $502M | $631M | $702M | $750M |
| Net income | $369M | $353M | $631M | $514M | $552M |
| Diluted EPS | $1.91 | $1.88 | $3.41 | $2.85 | $3.13 |
| Net margin | 9.2% | 8.1% | 14.1% | 10.8% | 10.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$5.62B
EV / EBITDA—
EV / Sales1.1
EV / FCF7.7
P / FCF6.7
PEG (trailing)1.23
Earnings yield11.2%
FCF yield14.9%
Quality & risk
ROIC (est.)14.5%
Free cash flow$735M
Total debt$1.54B
Net cash-$688M
Altman Z-Score2.74 grey
Piotroski F-Score6/9
Capital returns
Buyback yield5.1%
Dividend yield (est.)2.4%
Shareholder yield7.5%
Shares Δ YoY-3.3%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRoutine disclosure cadence — no material red flags in recent filings.
Recent filings
all on EDGAR ↗SCHEDULE 13GFiling2026-05-15open ↗10-QPeriod ending 2026-03-312026-05-08open ↗8-KPeriod ending 2026-05-072026-05-07open ↗SCHEDULE 13GFiling2026-04-29open ↗SCHEDULE 13GFiling2026-04-29open ↗8-KPeriod ending 2026-04-232026-04-29open ↗4Period ending 2026-04-232026-04-27open ↗4Period ending 2026-04-232026-04-27open ↗4Period ending 2026-04-232026-04-27open ↗4Period ending 2026-04-232026-04-27open ↗4Period ending 2026-04-232026-04-27open ↗4Period ending 2026-04-232026-04-27open ↗
Frequently asked
- Is Genpact LTD (G) a buy?
- G currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. Steady digital-operations compounder — revenue +6.6%, 21.7% ROE, strong cash flow — at a cheap 9x earnings, with AI as the swing factor.
- What is G's fair value?
- A Modified-Graham model based on G's SEC fundamentals estimates a fair value of about $65.72. It is an estimate from reported earnings, not a price target.
- Is G overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, G currently appears undervalued relative to its SEC-grounded earnings power.
- What is Genpact LTD's quality score?
- G scores 71.94340186516816/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001398659, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/21/2026, 9:00:58 PM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 5:00 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.